Ireland - English - HPRA (Health Products Regulatory Authority)

laboratorios hipra s.a. - f4ab fimbrial adhesin of e.coli; f4ac fimbrial adhesin of e.coli; f5 fimbrial adhesin of e.coli; f6 fimbrial adhesin of e. coli; lt enterotoxoid of e. coli; clostridium perfringens, type c toxoid; clostridium novyi, type b toxoid - suspension for injection - . - escherichia + clostridium - pigs - immunological - inactivated vaccine

Australia - English - Department of Health (Therapeutic Goods Administration)

prinz herget pty ltd t/a natural therapy imports - escherichia coli strain nissle 1917, quantity: 0.25 billion cfu - capsule, enteric - excipient ingredients: triethyl citrate; macrogol 4000; titanium dioxide; iron oxide red; glycerol; shellac; white beeswax; maltodextrin; carnauba wax; purified talc; methacrylic acid copolymer; potable water; gelatin; sodium lauryl sulfate - for the relief and management of chronic constipation.,increases the number of bowel movements per day and the number of days on which bowel movements occur in patients with chronic constipation.

Philippines - English - FDA (Food And Drug Administration)

zoetis philippines, inc.; distributor: zoetis philippines, inc. - escherichia coli live culture vaccine (vet.) - freeze-dried powder for suspension (oral/aerosol) - formulation: each dose contains: escherichia coli (serotype 078, ec#4195 strain) ..................>1.7 x 10^2 cfu cfu - colony forming unit

Philippines - English - FDA (Food And Drug Administration)

msd animal health (phils.), inc. - escherichia coli fimbrial adhesins , clostridium perfringens vaccine (vet.) - suspension for injection (im) - each (2 ml) dose contains: escherichia coli (f4ab adhesin) (ja221-ppab-2 strain) ............ e. coli (f4ac adhesin) (5k-ppac-2 strain) ... ... ... ... ... ... ... ... ... ... e. coli (f5 adhesin) (dh5q-pk99-blue strain) ............. e. coli (f6 adhesin) (987p-5 strain) .............................. e. coli (lt toxoid) (ja221-pplt-1 strain) ...... clostridium perfringens type c antigen (578 strain) .......... ab-antibody titre 29.3 log2 ab titre 26.5 log2 ab titre 27.5 log2 ab titre 27.4 log2 ab titre 210.5 log2 ab titre 20 iu

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - bovine rotavirus, bovine coronavirus inactivated, e.coli k99 antigen - emulsion for injection - unknown - inactivated bovine rotavirus vaccine + inactivated bovine coronavirus vaccine + inactivated escheri - bovine - immunological - inactivated vaccine

United Kingdom - English - VMD (Veterinary Medicines Directorate)

kernfarm b.v. - bovine coronavirus, bovine rotavirus, escherichia coli - emulsion for injection - inactivated viral and bacterial vaccine - cattle

Ireland - English - HPRA (Health Products Regulatory Authority)

merial animal health limited - inactivated bovine coronavirus strain f15, inactivated bovine rotavirus strain ro1, inactivated e.coli k99 strain serotype o101, inactivated e.coli y strain serotype o117, inactivated e.coli f41 strain serotype o101, e.coli 31a antigen - suspension for injection - unknown - inactivated bovine rotavirus vaccine + inactivated bovine coronavirus vaccine + inactivated escheri - bovine - immunological - inactivated vaccine

United Kingdom - English - VMD (Veterinary Medicines Directorate)

boehringer ingelheim animal health uk ltd - bovine coronavirus, bovine rotavirus, escherichia coli - suspension for injection - inactivated viral and bacterial vaccine - cattle

Australia - English - Department of Health (Therapeutic Goods Administration)

key diagnostics pty ltd - ct784 - escherichia coli (e. coli) ivds - ivds intended to aid in the diagnosis of disease caused by escherichia coli (e. coli) including e. coli that produce shiga toxin or vero toxin.

European Union - English - EMA (European Medicines Agency)

prevtec microbia gmbh - live non-pathogenic escherichia coli o8:k87 - immunologicals for suidae, live bacterial vaccines, pig - pigs - for active immunisation of pigs against enterotoxigenic f4-positive escherichia coli in order to:reduce the incidence of moderate to severe post-weaning escherichia coli diarrhoea (pwd) in pigs;reduce the colonisation of the ileum and faecal shedding of enterotoxigenic f4-positive escherichia coli from infected pigs.